Recent Updates
Recently added Catalysts
CODX Positive Sentiment Score: 75/100

Co-Diagnostics, Inc. to Host Booth at 89th Annual AMCA Conference in Reno, NV on Feb 28-March 3

Tuesday, February 28, 2023 2 min read
Key Takeaway: Co-Diagnostics, Inc. will host a booth at the 89th annual American Mosquito Control Association (AMCA) conference from February 28 to March 3 in Reno, Nevada. This conference is a significant event for education and networking among mosquito control professionals and offers Co-Diagnostics an opportunity to present its vector control PCR products. The company has noted growth in laboratory installations and reagent purchases over the past year, indicating a positive trajectory in its business activities.

Market Sentiment Analysis

POSITIVE FACTORS

  • Co-Diagnostics is participating in a premier event for networking and education.
  • The company is showcasing its vector control PCR products to industry professionals.
  • There has been growth in laboratory installations and reagent purchases for Co-Diagnostics in the past year.

Full Press Release Details

SALT LAKE CITY, Feb. 28, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the upcoming 89th annual American Mosquito Control Association (AMCA) conference on February 28-March 3 in Reno, Nevada.
The AMCA Annual Meeting is listed as the premier education and networking event for researchers, educators, vector control professionals, industry representatives, and students in mosquito control. Co-Dx believes the event will provide opportunities for Company representatives to introduce Co-Diagnostics vector control PCR products to a wide array of professionals in the field, following a year where the Company saw growth in terms of both new laboratory installations and reagent purchases from existing customers.
To learn more about the conference, including registration details, please visit https://www.eventscribe.net/2023/AMCA. Attendees interested in learning more about the Company and its products, including its suite of Vector Smart™ tests and other equipment, are invited to visit Booth #107.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.
SOURCE Co-Diagnostics

21 %

more press release views with

Frequently Asked Questions

What event will Co-Diagnostics attend in March 2023?

Co-Diagnostics will participate in the 89th annual AMCA conference from February 28 to March 3.

Where is the AMCA conference being held?

The AMCA conference will take place in Reno, Nevada.

What products will Co-Diagnostics showcase?

Co-Diagnostics will introduce its Vector Smart™ tests at Booth #107.

Who can attend the AMCA Annual Meeting?

The event is open to researchers, educators, vector control professionals, and students.

How can I learn more about the conference?

For more details, visit the AMCA conference registration page at eventscribe.net.

Tags: CODX Viatris Investor Conferences Healthcare Co-Diagnostics AMCA conference molecular diagnostics PCR products Reno
Last updated: Feb 28, 2023